
    
      This first clinical study will assess the acceptability of the tool both by caregivers at the
      13 pain clinics and by a panel of 300 patients followed for 6 months. Based on the results of
      the study (end 2019), investigator will improve the tool in a version 2.0, which will then be
      evaluated in a large impact study, measuring the intrinsic therapeutic effect of eDOL.
    
  